ES2065471T3 - Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos. - Google Patents

Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos.

Info

Publication number
ES2065471T3
ES2065471T3 ES90202169T ES90202169T ES2065471T3 ES 2065471 T3 ES2065471 T3 ES 2065471T3 ES 90202169 T ES90202169 T ES 90202169T ES 90202169 T ES90202169 T ES 90202169T ES 2065471 T3 ES2065471 T3 ES 2065471T3
Authority
ES
Spain
Prior art keywords
bacteriophagus
surfactant
compositions including
aqueous compositions
antibacterial aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90202169T
Other languages
English (en)
Inventor
Carol Lesley Jones
George Kerr Rennie
Charles Herbert Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2065471T3 publication Critical patent/ES2065471T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/381—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ESTA DESCRITA UNA COMPOSICION DE INTENCION HIGIENICA PARA COMBATIR MICROORGANISMOS QUE COMPRENDEN EN UN MEDIO COMPATIBLE QUE CONTIENE AL MENOS UN AGENTE ORGANICO DE SUPERFICIE ACTIVA, UNA CANTIDAD EFECTIVA DE UNO O MAS VIRUS CAPACES DE ANULAR UNO O MAS DE LOS MICROORGANISMOS. LOS BACTERIOFAGOS SON UTILIZADOS PREFERENTEMENTE PARA COMBATIR BACTERIAS INDESEABLES. LAS COMPOSICIONES PUEDEN UTILIZARSE COMO POTENTES LIMPIADORES DE SUPERFICIE.
ES90202169T 1989-08-21 1990-08-10 Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos. Expired - Lifetime ES2065471T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918983A GB8918983D0 (en) 1989-08-21 1989-08-21 Composition for hygiene purposes

Publications (1)

Publication Number Publication Date
ES2065471T3 true ES2065471T3 (es) 1995-02-16

Family

ID=10661903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90202169T Expired - Lifetime ES2065471T3 (es) 1989-08-21 1990-08-10 Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos.

Country Status (9)

Country Link
EP (1) EP0414304B1 (es)
JP (1) JPH07103005B2 (es)
AU (1) AU637806B2 (es)
BR (1) BR9004130A (es)
CA (1) CA2023556A1 (es)
DE (1) DE69013812T2 (es)
ES (1) ES2065471T3 (es)
GB (1) GB8918983D0 (es)
ZA (1) ZA906621B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2253859A (en) * 1991-02-28 1992-09-23 Microbial Dev Ltd Use of bacteriophages to prevent microbial infestation
US5374433A (en) * 1991-11-20 1994-12-20 Monfort, Inc. Method for preserving food products
US6287610B1 (en) 1991-11-20 2001-09-11 Monfort, Inc. Method for increasing the tenderness of a meat product
JPH06100409A (ja) * 1992-09-17 1994-04-12 Japan Tobacco Inc 冷凍空調機器用冷却水域における細菌防除法
AU7228294A (en) * 1993-07-01 1995-01-24 Unilever Plc Oral care compositions
EP0776163A4 (en) * 1994-09-09 1999-11-24 Univ Maryland BACTERIOPHAGE-ENCODING ENZYMES FOR THE TREATMENT AND PREVENTION OF DENTAL CARIES AND PERIODONTAL DISEASES
AU734420B2 (en) * 1996-04-15 2001-06-14 Nymox Corporation Compositions containing bacteriophages and methods of using bacteriophages to treat infections
AU7113398A (en) * 1997-04-24 1998-11-13 Idaho Research Foundation Inc., The Phages, methods for growing and detecting them and their use
EP0983077A1 (en) * 1997-05-15 2000-03-08 Ribozyme Pharmaceuticals, Inc. Pharmaceutical composition and diagnostic kit directed to a heterologeneous pathogenic organism in a host
US6559116B1 (en) 1999-09-27 2003-05-06 The Procter & Gamble Company Antimicrobial compositions for hard surfaces
CN1230206C (zh) * 2000-01-11 2005-12-07 内立蒂克斯股份有限公司 作为生产生物复合材料的生物可降解基质的聚合物混合物
US6485902B2 (en) 2000-06-06 2002-11-26 Thomas E. Waddell Use of bacteriophages for control of escherichia coli O157
WO2003008564A2 (en) 2001-07-18 2003-01-30 Instytut Immunologii I Terapii Doswiadczalnej Pan Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
GB0209680D0 (en) * 2002-04-27 2002-06-05 Univ Strathclyde Immobilisation and stabilisation of bacteriophage
JP5127708B2 (ja) * 2005-07-12 2013-01-23 マイクレオス べスローテン フェンノートシャップ バクテリオファージ及びその使用
CN101652144B (zh) * 2007-02-28 2013-08-14 欧姆尼利蒂克斯公司 使用噬菌体对动物的外层消毒
WO2009076668A2 (en) 2007-12-13 2009-06-18 Alpharma, Inc. Bacteriophage preparations and method of use thereof
DE102008005193A1 (de) 2008-01-18 2009-07-23 Dahlen, Neithard Bakteriophagenpräparation und Verwendung
WO2009101615A1 (en) * 2008-02-12 2009-08-20 Technion Research & Development Foundation Ltd. Methods and compositions for controlling body odor
PL215522B1 (pl) 2008-09-29 2013-12-31 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
BE1018502A3 (nl) * 2009-02-17 2011-02-01 Metatecta Nv Probiotische oplossing voor het beschermen van een oppervlak en werkwijze die gebruik maakt van zulke oplossing.
AU2010212280B2 (en) * 2009-08-12 2015-09-24 Buddhist Tzu Chi Medical Foundation Phage of acinetobacter Baumannii
DE102009029423A1 (de) * 2009-09-14 2011-03-24 Henkel Ag & Co. Kgaa Antibakterielle kosmetische oder pharmazeutische, zur Körperdeodorierung geeignete Zusammensetzungen gegen Körpergeruch
PL212258B1 (pl) 2010-06-20 2012-09-28 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas
US9937087B2 (en) 2014-01-24 2018-04-10 The Procter & Gamble Company Disposable absorbent articles comprising skin health composition(s) and related methods
EP3096841B1 (en) * 2014-01-24 2018-04-11 The Procter and Gamble Company Skin care wipes comprising added natural antibacterial agents
GB201402139D0 (en) 2014-02-07 2014-03-26 Fixed Phage Ltd Treatment of topical and systemic bacterial infections
GB2540688B (en) 2014-03-31 2021-04-21 Kimberly Clark Co Self-regenerating antimicrobial composition and method of use
WO2016168560A1 (en) 2015-04-16 2016-10-20 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli o157:h7 bacteriophage φ241
ITUB20150028A1 (it) * 2015-04-22 2016-10-22 Copma S C A S R L Prodotto per la pulizia, la sanificazione e l'igienizzazione
WO2016207725A1 (en) * 2015-06-23 2016-12-29 Phagelux (Canada), Inc. Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof
IT201600095070A1 (it) * 2016-09-22 2018-03-22 Copma S C A R L Prodotto detergente per uso cosmetico
EP3538220B1 (en) 2016-11-09 2026-07-22 Universidad Andres Bello Pharmaceutical composition based on bacteriophages against f. nucleatum; use in the treatment of diseases associated with this pathogen
CN111150518A (zh) * 2020-03-05 2020-05-15 武天逾 一种新型抗菌牙套及其制备方法
EP4683992A1 (en) * 2023-03-20 2026-01-28 Unilever IP Holdings B.V. A composition for reducing urine malodour
WO2024204528A1 (ja) * 2023-03-30 2024-10-03 株式会社カネカ 植物病害防除方法、植物病害防除組成物、及び塩化ナトリウムの使用
JPWO2024204527A1 (es) * 2023-03-30 2024-10-03
WO2026021797A1 (en) * 2024-07-26 2026-01-29 Unilever Ip Holdings B.V. A composition for biofilm disruption
WO2026037602A1 (en) * 2024-08-13 2026-02-19 Unilever Ip Holdings B.V. A hygiene composition
WO2026057305A1 (en) * 2024-09-12 2026-03-19 Unilever Ip Holdings B.V. A hygiene composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2511258A1 (de) * 1975-03-14 1976-09-23 Helmut Prof Dr Med Stickl Praeparate zur lokalen behandlung der akne-vulgaris und verfahren zu ihrer herstellung
JPS58225006A (ja) * 1982-06-25 1983-12-27 Suntory Ltd 養毛化粧料
JPS60159596A (ja) * 1984-01-30 1985-08-21 Agency Of Ind Science & Technol 生物汚損防止方法
DE3581091D1 (de) * 1984-03-09 1991-02-07 Advance Kk Anti-karies- oder anti-periodontitismittel.
JPS6290393A (ja) * 1985-10-17 1987-04-24 工業技術院長 製紙工程におけるスライム障害防止方法
JPS62123104A (ja) * 1985-11-22 1987-06-04 Japan Tobacco Inc ナス科植物の土壌病害防除方法
JPS6440409A (en) * 1987-08-06 1989-02-10 Fuji Spinning Co Ltd Molded chitosan product containing immobilized bacteriophage
JPH01163108A (ja) * 1987-12-21 1989-06-27 Kansai Electric Power Co Inc:The 海洋性生物汚損防止方法
US4891210A (en) * 1989-01-03 1990-01-02 Norris Alan H Use of bacteriophages in dental hygiene
AU3579889A (en) * 1989-05-03 1990-11-29 Le Roy E. Jackson Bacteriophage prevention and control of harmful plant bacteria

Also Published As

Publication number Publication date
JPH03118306A (ja) 1991-05-20
EP0414304A2 (en) 1991-02-27
JPH07103005B2 (ja) 1995-11-08
AU637806B2 (en) 1993-06-10
GB8918983D0 (en) 1989-10-04
ZA906621B (en) 1992-04-29
CA2023556A1 (en) 1991-02-22
AU6110990A (en) 1991-02-21
EP0414304B1 (en) 1994-11-02
EP0414304A3 (en) 1992-01-02
BR9004130A (pt) 1991-09-03
DE69013812T2 (de) 1995-03-30
DE69013812D1 (de) 1994-12-08

Similar Documents

Publication Publication Date Title
ES2181725T3 (es) Inhibidores de hiv proteasa.
ES2161210T3 (es) Composiciones anti-patogenamente eficaces que comprenden peptidos liticos y enzimas hidroliticas.
BR8501084A (pt) Processo para preparar uma composicao aquosa adequada para uso oftalmico e processo para limpar,desinfetar e preservar lentes de contato
ES2044912T3 (es) Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion.
ES2078738T3 (es) Composicion y procedimiento para eliminar o prevenir la aparicion de biopeliculas.
BR0014549A (pt) Artigo elástico
AR023807A1 (es) Un agente para tratar el ojo seco y el uso de un compuesto macrolido para preparar composiciones farmaceuticas para el tratamiento del ojo seco
BR9605815A (pt) Uso de amidoaminas em composições oftálmicas
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9814299A (pt) Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
CO5031254A1 (es) Panos limpiadores absorbentes impregnados con una composi- cion limpiadora antimicrobial
ES2174921T3 (es) Inhibidores de la proteasa del vih.
ES2194535T3 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contien y su uso como agente parala lucha contra organismos dañinos.
ES2094247T3 (es) Utilizacion de un desinfectante acuoso que contiene acido citrico para desactivar el virus de la hepatitis b y esporas bacterianas.
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
NO20023630D0 (no) Anvendelse av retinoid-type forbindelser som antibakterielle midler
ES2056577T3 (es) Composicion biocida y uso.
BR0108497A (pt) Composição fungicidas tolerantes inoculantes
AR027122A1 (es) Composicion paa el tratamiento de tejidos danados
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
BR9713875A (pt) Composição aquosa concentrada desinfetante e de limpeza, e, processo para limpeza e/ou desinfecção de uma superfìcie dura
ES2121109T3 (es) Composicion de champu.
CO4970789A1 (es) Composiciones para el cuidado de la piel
EP0485486A4 (en) Process for disinfecting musculoskeletal tissue and tissues prepared thereby

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414304

Country of ref document: ES